DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Gynecologic Condition

Bacterial Vaginosis

LOW SEVERITY

The most common vaginal infection in women of reproductive age, caused by disruption of normal vaginal flora with overgrowth of anaerobic bacteria. Not sexually transmitted but associated with sexual activity. Increases risk of STI acquisition, pelvic inflammatory disease, and pregnancy complications.

Global Affected

21.0M

Countries

22

Symptoms

Thin grayish-white vaginal discharge
Fishy odor (especially after intercourse)
Vaginal itching
Burning during urination
Many women are asymptomatic
Postcoital bleeding in some cases
Vulvar irritation

Treatment Options

Metronidazole (oral or vaginal gel)
Clindamycin (oral or vaginal cream)
Tinidazole (oral)
Probiotic supplementation
Boric acid suppositories for recurrent cases
Evaluation and treatment of sexual partners not routine
Lactobacillus colonization therapy (investigational)

Risk Factors

1Multiple sexual partners
2New sexual partner
3Douching (disrupts vaginal pH)
4Lack of vaginal lactobacilli
5Smoking
6Intrauterine device (IUD) use
7Antibiotic use
8Hormonal contraception changes

Diagnostic Methods

  • 1Amsel criteria (3 of 4: thin discharge, clue cells, pH >4.5, fishy odor)
  • 2Nugent score (Gram stain scoring)
  • 3Vaginal pH testing
  • 4Wet mount microscopy
  • 5DNA probe tests
  • 6Culture (limited utility)

Prognosis

Bacterial vaginosis responds to antibiotics in 70-90% of cases within 1 week. Recurrence is common, affecting 50-80% within 12 months. Chronic or recurrent BV significantly impacts quality of life. Treatment during pregnancy reduces preterm birth risk. Asymptomatic BV often does not require treatment except before gynecologic procedures or during pregnancy. Long-term complications can include increased HIV susceptibility and pelvic inflammatory disease.

Prevention

  • Avoiding vaginal douching
  • Limiting number of sexual partners
  • Using condoms consistently
  • Probiotic supplementation
  • Stopping smoking
  • Maintaining vaginal health with appropriate hygiene

Research Status

Treatment with antibiotics is highly effective but recurrence common (30% within 3 months). Research on probiotics, vaginal microbiome transplantation, and biofilm-disrupting therapies. Increasing recognition of role in HIV transmission and pregnancy outcomes.

Sources

  • https://www.cdc.gov/std/bv
  • https://www.mayoclinic.org/diseases-conditions/bacterial-vaginosis
  • https://www.who.int/news-room/fact-sheets/detail/bacterial-vaginosis

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.